134 related articles for article (PubMed ID: 31966654)
1. Effects of ASPP2 on proliferation and apoptosis of malignant spinal tumor cells.
Huang W; Li X; Cai L
Int J Clin Exp Pathol; 2017; 10(7):8023-8030. PubMed ID: 31966654
[TBL] [Abstract][Full Text] [Related]
2. ASPP2 enhances chemotherapeutic sensitivity through the down-regulation of XIAP expression in a p53 independent manner in hepatocellular carcinoma.
Yang T; Gao Y; Liu D; Wang Y; Wu J; Liu X; Shi Y; Chen D
Biochem Biophys Res Commun; 2019 Jan; 508(3):769-774. PubMed ID: 30528232
[TBL] [Abstract][Full Text] [Related]
3. Prognostic values of apoptosis-stimulating P53-binding protein 1 and 2 and their relationships with clinical characteristics of esophageal squamous cell carcinoma patients: a retrospective study.
Xie XF; Yang Q; Chi J; Yang XZ; Wang HY; Xu GL
Chin J Cancer; 2017 Jan; 36(1):15. PubMed ID: 28103919
[TBL] [Abstract][Full Text] [Related]
4. ASPP2 enhances oxaliplatin (L-OHP)-induced colorectal cancer cell apoptosis in a p53-independent manner by inhibiting cell autophagy.
Shi Y; Han Y; Xie F; Wang A; Feng X; Li N; Guo H; Chen D
J Cell Mol Med; 2015 Mar; 19(3):535-43. PubMed ID: 25534115
[TBL] [Abstract][Full Text] [Related]
5. Nuclear EGFR impairs ASPP2-p53 complex-induced apoptosis by inducing SOS1 expression in hepatocellular carcinoma.
Liu K; Jiang T; Ouyang Y; Shi Y; Zang Y; Li N; Lu S; Chen D
Oncotarget; 2015 Jun; 6(18):16507-16. PubMed ID: 25980493
[TBL] [Abstract][Full Text] [Related]
6. [Phosphorylation status of ASPP2 modulates p53 apoptotic function in oxaliplatin-induced apoptosis of colorectal cancer HCT116 cells].
Hou Q; Zhao H; Gong W; Zhu Z; Han Y; Chen D; Guo H
Zhonghua Zhong Liu Za Zhi; 2014 Jun; 36(6):418-23. PubMed ID: 25241782
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis stimulating protein of p53 (ASPP) 1 and ASPP2 m-RNA expression in oral cancer.
Patel KD; Barasiya YV; Patel JB; Patel PS
Arch Oral Biol; 2020 Nov; 119():104920. PubMed ID: 32987288
[TBL] [Abstract][Full Text] [Related]
8. Silencing of ASPP2 promotes the proliferation, migration and invasion of triple-negative breast cancer cells via the PI3K/AKT pathway.
Wu T; Song H; Xie D; Zhao B; Xu H; Wu C; Hua K; Deng Y; Ji C; Hu J; Fang L
Int J Oncol; 2018 Jun; 52(6):2001-2010. PubMed ID: 29568874
[TBL] [Abstract][Full Text] [Related]
9. p53 target DDA3 binds ASPP2 and inhibits its stimulation on p53-mediated BAX activation.
Sun WT; Hsieh PC; Chiang ML; Wang MC; Wang FF
Biochem Biophys Res Commun; 2008 Nov; 376(2):395-8. PubMed ID: 18793611
[TBL] [Abstract][Full Text] [Related]
10. Synergistic inhibitory effects on hepatocellular carcinoma with recombinant human adenovirus Aspp2 and oxaliplatin via p53-independent pathway in vitro and in vivo.
Liu X; Xu J; Wang S; Yu X; Kou B; Chai M; Zang Y; Chen D
Int J Oncol; 2017 Oct; 51(4):1291-1299. PubMed ID: 28902369
[TBL] [Abstract][Full Text] [Related]
11. [Promoter methylation of ASPP1 and ASPP2 genes in non-small cell lung cancers].
Wei WL; Hu HY; Zhang LJ; Chen Y; Ye E; Wang XF
Zhonghua Bing Li Xue Za Zhi; 2011 Aug; 40(8):532-6. PubMed ID: 22169642
[TBL] [Abstract][Full Text] [Related]
12. Amphiregulin impairs apoptosis-stimulating protein 2 of p53 overexpression-induced apoptosis in hepatoma cells.
Liu K; Lin D; Ouyang Y; Pang L; Guo X; Wang S; Zang Y; Chen D
Tumour Biol; 2017 Mar; 39(3):1010428317695026. PubMed ID: 28351301
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus core protein interacts with p53-binding protein, 53BP2/Bbp/ASPP2, and inhibits p53-mediated apoptosis.
Cao Y; Hamada T; Matsui T; Date T; Iwabuchi K
Biochem Biophys Res Commun; 2004 Mar; 315(4):788-95. PubMed ID: 14985081
[TBL] [Abstract][Full Text] [Related]
14. DNA damage regulated autophagy modulator 1 recovers the function of apoptosis-stimulating of p53 protein 2 on inducing apoptotic cell death in Huh7.5 cells.
Liu D; Li R; Guo X; Pang L; Zang Y; Liu K; Chen D
Oncol Lett; 2018 Jun; 15(6):9333-9338. PubMed ID: 29844830
[TBL] [Abstract][Full Text] [Related]
15. [TP53BP2/ASPP2 inhibits autophagy of HepG2 cells by activating mTOR pathway in a p53-independent manner].
Xu P; Shi H; Jiao Y; Chen D; Shi H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Nov; 35(11):986-991. PubMed ID: 31878994
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of ASPP2 in choriocarcinoma contributes to increased migratory potential through Src signaling pathway activation.
Mak VC; Lee L; Siu MK; Wong OG; Lu X; Ngan HY; Wong ES; Cheung AN
Carcinogenesis; 2013 Sep; 34(9):2170-7. PubMed ID: 23671128
[TBL] [Abstract][Full Text] [Related]
17. ASPP2 promotes cell apoptosis in cervical cancer through inhibiting autophagy.
Jiang F; Bian G; Li J
Exp Ther Med; 2022 Dec; 24(6):726. PubMed ID: 36340606
[TBL] [Abstract][Full Text] [Related]
18. Expression and significance of ASPP2 in squamous carcinoma of esophagus.
Liu B; Yang L; Li XJ; Li R; Sun W; Chen XY; Liu JC
Kaohsiung J Med Sci; 2018 Jun; 34(6):321-329. PubMed ID: 29747775
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis stimulating protein of p53 (ASPP2) expression differs in diffuse large B-cell and follicular center lymphoma: correlation with clinical outcome.
Lossos IS; Natkunam Y; Levy R; Lopez CD
Leuk Lymphoma; 2002 Dec; 43(12):2309-17. PubMed ID: 12613517
[TBL] [Abstract][Full Text] [Related]
20. [ASPP2 inhibits oxaliplatin-induced autophagy and promotes apoptosis of colon cancer cells].
Wang B; Qiao L; Shi Y; Feng X; Chen D; Guo H
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jul; 31(7):898-904. PubMed ID: 26146058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
